Updates

July 30, 2026 To, To, Dy. General Manager, The Manager – Listing, Department of Corporate Services, National Stock Exchange of India Ltd, BSE Ltd., Plot No. C/1, G Block, P.J. Towers, Dala Street, Bandra Kurla Complex, Fort, Mumbai 400 001 Bandra (E), Mumbai – 400 051 Ref: Scrip Code: 543322 Ref: Scrip Name: ALIVUS Dear Sir, Sub.: Allotment of Equity Shares under the ‘Employee Stock Option Scheme, 2021’ We would like to inform you that, the Board of Directors of the Company at its meeting held today i.e. July 30, 2026 has approved the allotment of 32,000 Equity shares of face value of Rs. 2/- each to the eligible employee who has exercised stock options under the ‘Employee Stock Option Scheme, 2021’. Consequent to the aforesaid allotment, the paid-up share capital of the Company has increased as under: From To 12,27,39,448 equity shares of Rs. 2 each 12,27,71,448 equity shares of Rs. 2 each aggregating aggregating to Rs. 24,54,78,896/- to Rs. 24,55,42,896/- Request you to kindly take the same on record. Thanking you, Yours faithfully, For Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) Rudalf Corriea Company Secretary & Compliance Officer Alivus Life Sciences Limited ( formerly Glenmark Life Sciences Limited ) Corporate Office: Registered Office: Technopolis Knowledge Park, A wingO, ffice No. 401 to 407, Plot No 170-172, Chandramouli Industrial Estate 4th Floor, Mahakali Caves Road, Andheri ( )E, Mumbai – 400093 Mohol Bazarpeth, Solapur 413 213, India T: +91 22 6829 7979 | CIN: L74900PN2011PLC139963 | E: complianceofficer@alivus.com | W: www.alivus.com